For the first time since launch, with our pharmacy stock tracking, patients are finally starting to recognise we are almost always reliably update ahead of official releases.
Anyone watching us over time recognises this already.
It genuinely takes multiple days for most clinics to action updates, and that often is dependent on commercial deals being made behind the scenes.
The point being made is that we're tired of being blamed for clinics/pharmacies saying "medications don't exist" when infact we're just the first to publish - and their own staff haven't bothered to update yet themselves. We receive most of the same stock updates they do.
MedBud is launching a full stock API for companies/clinicians across the industry, set to launch next week. We're hoping to make this available to bodies such as
@UKMCCS
.Let's have no more excuses please, if a medication is approved/available, clinicians have no justification for not considering it for treatment - this is arguably covered in
@GMCUK guidelines.
In all circumstances if a clinician is ignoring guidelines and trying to limit prescribing to a clinic's specific commercially-influenced formulary - they are breaking guidelines, that could cost them their medical license if ever under legal pressure.
The key to maintaining an open, accessible and unbiased industry, is strongly enforcing that clinicians must prescribe to all patients indiscriminately, irrespective of commercial influence – and in all instances.
